Holland Capital successfully raises a new private equity fund of EUR 225 million after a swift fundraising period
Amsterdam/Düsseldorf, March 5, 2024 – After a fundraising period of five months, Holland Capital has established its new investment fund, Holland Capital Growth & Buy Out Fund V. There was significant interest from both existing and new investors, leading to the fund being oversubscribed. As a result, a first-and-final closing occurred at the hard cap of EUR 225 million. Investors in this new fund include (international) institutional parties, family offices, and entrepreneurs (many of whom are active in Healthcare and Technology). The fund is classified as an Article 8 fund under the Sustainable Finance Disclosure Regulation (SFDR).
The fund will continue its existing strategy
Holland Capital will deploy the capital for investments in medium-sized Dutch and German companies operating in the Healthcare, Technology, and Agrifood-Tech sectors. This aligns the investment strategy of this fund with its previous funds. With the SFDR Article 8 classification and the related ESG objectives of the fund, Holland Capital reaffirms its ambitions in this regard.
The fund manager aims to realize 15 to 20 platform investments in the coming years with the available capital. Holland Capital benefits from a continuous and robust lead flow in the mentioned sectors. The first planned investments are already in the final stages of ‘due diligence.’
As an active shareholder, Holland Capital adds value by providing not only capital but also knowledge, a network, and hands-on support in the professionalization of the organization and realization of buy-and-build strategies. Over the past 40 years, Holland Capital has supported over 180 entrepreneurs in growing their businesses. Ewout Prins and Hubert Verbeek, managing partners at Holland Capital, state, “We very much look forward to collaborating with entrepreneurs in this fund, creating value by supporting their companies to a next phase.”
Margot Engels, operational partner & CEO at Holland Capital, “We are grateful for the trust of our investors. The overwhelming enthusiasm is a testament to confidence in Holland Capital’s distinctive approach.”
About Holland Capital
For over 40 years, Holland Capital has responsibly and successfully invested in promising Dutch and German SMEs with growth ambitions. The team understands entrepreneurship and aims for an open, sustainable, and professional relationship with the management teams of the invested companies, with the shared goal of achieving growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and recently added Agrifood-Tech sectors. The team is familiar with the dynamics and opportunities in these sectors and has an extensive network.
Following this successful fundraising, Holland Capital’s total assets under management amount to EUR 500 million, and it currently holds 38 companies in its portfolio. For the fund manager, this marks the eleventh and largest fund since the organization’s establishment in 1981.
AMP groep en 2MC bundelen krachten
Amsterdam/Houten, 14 november 2022 – Onze deelneming AMP Groep bundelt haar krachten met medisch logistiek bedrijf 2MC. Door de krachtenbundeling, die mede mogelijk wordt gemaakt door Holland Capital, breidt de organisatie haar positie in de medische logistieke...
AMP Group and 2MC join forces
Amsterdam/Houten, 14 November 2022 – Our portfolio company AMP Group joins forces with medical logistics company 2MC. By working together, which in part has been made possible by Holland Capital, the organization is significantly expanding its position in the medical...
Defibrion neemt DefibSolutions over en breidt haar activiteiten uit
Amsterdam, 1 november 2022 – Onze deelneming Defibrion neemt DefibSolutions over, een groothandel in AED’s en reanimatie artikelen. Met de krachtenbundeling versterkt Defibrion haar positie binnen de markt van AED’s en aanpalende producten en diensten op het gebied...
Defibrion acquires Defibsolutions and expands its business
Amsterdam, 1 November 2022 - Our portfolio company Defibrion acquires DefibSolutions, a wholesaler of AEDs and resuscitation products. By joining forces, Defibrion strengthens its market position in AEDs and related products & services in the field of emergency...
Channext haalt €4,5M Series A financiering op
Utrecht, 27 september 2022 - Partner marketing platform Channext haalt €4,5 miljoen financiering op. De Series A ronde wordt geleid door Holland Capital, die samen met het Graduate Entrepreneur Fund en huidige investeerders participeren. Met de investering wil...
Channext raises €4.5M Series A funding
Utrecht, 27 September 2022 - Partner marketing platform Channext has raised €4.5 million in funding. The series A round is led by Holland Capital, investing together with the Graduate Entrepreneur Fund and current investors. With this funding, Channext aims to become...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl



